SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: 5-(5-((3,5-Dimethylpiperazin-1-yl)sulfonyl)-2-ethoxyphenyl)-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: CCCC(C(NC(C(C=C1[S](=O)(N(CC2C)CC(N2)C)=O)=C(C=C1)OCC)=N3)=C4C3=O)=NN4C
Dimethyl Sildenafil is chemically 5-(5-((3,5-Dimethylpiperazin-1-yl)sulfonyl)-2-ethoxyphenyl)-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one. Dimethyl Sildenafil is supplied with detailed characterization data compliant with regulatory guideline. Dimethyl Sildenafil can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sildenafil .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Quantification of active pharmaceutical ingredient and impurities in sildenafil citrate obtained from the Internet
Michael A Veronin , Mohammad T Nutan , Uday Krishna Reddy Dodla
Ther Adv Drug Saf. 2014 Oct;5(5):180-9
Validated Methods for Determination of Sildenafil Citrate in The Presence of its Potential Impurities
A.E. El-Gindy , E. Shokry M. Farouk , L. Abd El-Aziz
J Biomed Sci and Res., Vol 2 (4), 2010,262-278
Validated LC method for sildenafil citrate related substances and its potential oxidative degradation product
A.Nageswari, P.Surya Prakash Rao, B.Gowri Sankar Rao, B.Satyanarayana , M.Saravanan , V.Ranga Reddy , Mukkanti
ACAIJ, 10(10) 2011 [683-690]
Determinaton of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLC
N Daraghmeh, M Al-Omari, A.ABadwan, A.M.YJaber
Journal of Pharmaceutical and Biomedical Analysis Volume 25, Issues 3–4, June 2001, Pages 483-492